Summary:
- The study found that lesser-known cannabinoids like CBG (cannabigerol) and THCV (tetrahydrocannabivarin) show promise as treatments for Parkinson's and Alzheimer's diseases.
- Researchers discovered that these cannabinoids can help reduce inflammation and oxidative stress, which are key factors in the development of neurodegenerative diseases.
- The study suggests that further research into the therapeutic potential of these lesser-known cannabis compounds could lead to new treatment options for Parkinson's, Alzheimer's, and other neurological conditions.